Publicacions - Fundació Institut d'Investigació en Ciències de la

Domènech E, Carrión S, Garcia-Planella E, Mañosa M, Gordillo J, Concepción M, Guarner C, Cabré E.
Smoking status and response to thiopurines in steroid-dependent inflammatory bowel disease.
INFLAMM BOWEL DIS 2010. DOI: 10.1002/ibd.21456
IF: 4,613
Domènech E, López San Román A, Garcia-Planella E.
How long should combined therapy with biological and immunomodulatory agents be maintained in
inflammatory bowel disease?
GASTROENTEROL HEPATOL 2010; 33:471-472
Domenech E, Zabana Y, Garcia-Planella E, Lopez San Roman A, Nos P, Ginard D, Gordillo J, Martinez-Silva
F, Beltran B, Mañosa M, Cabre E, Gassull MA.
Clinical outcome of newly diagnosed Crohn's disease: a comparative, retrospective studybefore and
after infliximab availability.
ALIMENT PHARM THER 2010 Jan15;31(2):233-9.
IF: 3,861
Domènech E, Zabana Y, Mañosa M, Garcia-Planella E, Cabré E, Gassull MA.
Infliximab reintroduction is not associated to a higher rate of immune-related adverse effects in patients
with inflammatory bowel disease initially treated with a three-infusion induction regimen.
J CLIN GASTROENTEROL 2010 Jan;44(1):34-7.
IF: 2,752
Fernandez-Rodriguez, CM; Alonso, S; Martinez, SM; Forns, X; Sanchez-Tapias, JM; Rincon, D; Rodriguez-
Caravaca, G; Barcena, R; Serra, MA; Romero-Gomez, M; Fernandez, I; Garcia-Samaniego, J; Fuente, J;
Sola, R; Moreno-Otero,R; Planas, R
Peginterferon plus ribavirin and sustained virological response in HCV-related cirrhosis: Outcomes and
factors predicting response
AM J GASTROENTEROL 2010 Oct;105(10):2164-72; quiz 2173. Epub 2010 Aug 10
IF: 6,882
Fernández-Rozadilla C, de Castro L, Clofent J, Brea-Fernández A, Bessa X, Abulí A, Andreu M, Jover R,
Xicola R, LlorX, Castells A, Castellví-Bel S, Carracedo A, Ruiz-Ponte C; Gastrointestinal Oncology Group of
the Spanish Gastroenterological Association.
Single nucleotide polymorphisms in the Wnt and BMP pathways and colorectal cancer risk in a Spanish
cohort.
PLOS ONE 2010 Sep 9;5(9). pii: e12673.
IF: 4,411
Fernández-Rozadilla C, Tarrío R, Clofent J, de Castro L, Brea-Fernández A, Bessa X, Abulí A, Andreu M,
Jover R, Xicola R, Llor X, Castells A, Castellví-Bel S, Carracedo A, Ruiz-Ponte C; Gastrointestinal Oncology
Group of the Spanish Gastroenterological Association.
Colorectal cancer susceptibility quantitative trait loci in mice as a novel approach to detect lowpenetrance
variants in humans: a two-stage case-control study.
CANCER EPIDEM BIOMAR 2010 Feb;19(2):619-23.
IF: 4,19
Garcia-Retortillo M, Morillas RM, Miquel M, Rodríguez-López O, Cirera I, Vergara M, Sala M, Giménez
MD, Cañete N, Gallach M, Ardèvol M, Alvárez MA, Montoliu S, Romero-Gómez M, Planas R, Solà R.
Factors predictius de desposta virològica sostinguda en pacients amb desposta virológica precoç
completa al tractament de l’hepatitis C
Pàgina 15 de 148